Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Halozyme Therapeutics Inc., 2 years.
Halozyme Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Halozyme Therapeutics Inc. | Option exercise | +7,304 | $38.46 | $280,912 |
| Jun 29, 2026 | Halozyme Therapeutics Inc. | Open-market sale | −7,304 | $75.00 | $547,800 |
| May 5, 2026 | Halozyme Therapeutics Inc. | Grant or award | +3,796 | — | — |
| May 1, 2025 | Halozyme Therapeutics Inc. | Grant or award | +4,165 | — | — |
| Apr 25, 2024 | Halozyme Therapeutics Inc. | Grant or award | +6,501 | — | — |
Questions about Mahesh Krishnan
What boards is Mahesh Krishnan on?
Mahesh Krishnan sits on the board of Halozyme Therapeutics Inc.
How long has Mahesh Krishnan served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.